ArticleExperimental and therapeutic medicine2023

ERBB3 mediates the PI3K/AKT/mTOR pathway to alter the epithelial‑mesenchymal transition in cervical cancer and predict immunity filtration outcome.

Xiaoyue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.